Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease that causes chronic weakness, in which antibodies attack receptors in the body and prevent muscle contraction; and

Whereas, MG frequently weakens muscles that control eye movement, facial expressions, and swallowing, and its symptoms may include blurred vision, speech impairment, difficulty chewing, shortness of breath, an unstable gait, and a weakened grip; and

Whereas, a diagnosis of MG may be missed or delayed because it shares symptoms in common with many other disorders; and

Whereas, in some cases, MG symptoms can worsen to the point of disability, grave illness, or death, if there are gaps in or an absence of the several crucial health care treatments that can enable those who endure MG to lead productive, active lives of normal longevity; and

Whereas, MG is found most commonly in adult women under 40 and men over 60, but is not specific to either gender or any particular ethnic background; and

Whereas, MG is nonhereditary and noncontagious; and

Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and support groups exist in Wisconsin for those people; now, therefore, be it